tyv2vd1p | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Choy%2C_Kay_Weng>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/s2666-5247%2820%2930168-3>
?:doi	10.1016/s2666-5247(20)30168-3
?:journal	Lancet_Microbe
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/129d8f751f98e8df3884b62d9a3ad231d8a5866b.json
?:pmc_json_files	document_parses/pmc_json/PMC7837007.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7837007>
?:pmid	<https://research.tib.eu/covid-19/entity/33521724.0>
?:pmid	33521724.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/129d8f751f98e8df3884b62d9a3ad231d8a5866b>
?:source	Elsevier; Medline; PMC
?:title	Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-04

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/tyv2vd1p>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/tyv2vd1p>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all